Briefing
SB amalgamation
The Board of Schenectady-Beck (SB) has approved the scheme of amalgamation of Schenectady India limited (SIL) with the company.Lupharma UK notice to acquire 51% in Knoll
Knoll Pharmaceuticals has informed the BSE that the company has received from Lupharma UK Holding One Limited, the notice of acquisition of 51 per cent equity in the company.
Copyright © 2001 Indian Express Newspapers (Bombay) Ltd.